Amphastar Pharmaceuticals (AMPH) Share-based Compensation (2013 - 2026)
Amphastar Pharmaceuticals (AMPH) posted quarterly Share-based Compensation of $31.1 million for Q1 2026, up 270.55% year-over-year from $8.4 million in Q1 2025, and up 401.21% quarter-over-quarter from $6.2 million in Q4 2025.
Amphastar Pharmaceuticals (AMPH) Share-based Compensation (2013 - 2026) Analysis & Trends
Amphastar Pharmaceuticals' Share-based Compensation history runs 14 years deep, the most recent figure standing at $31.1 million for Q1 2026.
- In Q1 2026, Share-based Compensation rose 270.55% year-over-year to $31.1 million; the TTM figure through Mar 2026 stood at $31.1 million (up 22.44% YoY), while the FY2025 annual figure was $27.3 million, up 11.94% from the prior year.
- Share-based Compensation for Q1 2026 stood at $31.1 million, up from $6.2 million in the prior quarter.
- The five-year high for Share-based Compensation was $31.1 million in Q1 2026, with the low at $4.2 million in Q2 2022.
- The 5-year median for Share-based Compensation is $5.6 million (2024), against an average of $9.3 million.
- Peak annual rise in Share-based Compensation reached 759.8% in 2022, while the deepest fall reached 30.39% in 2022.
- Amphastar Pharmaceuticals' Share-based Compensation stood at $4.3 million in 2022, then gained by 7.39% to $4.6 million in 2023, then gained by 21.85% to $5.6 million in 2024, then rose by 10.17% to $6.2 million in 2025, then soared by 401.21% to $31.1 million in 2026.
- Business Quant data shows AMPH's Share-based Compensation at $31.1 million in Q1 2026, $6.2 million in Q4 2025, and $23.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 40.00 Mn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 26.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 114.12 Mn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 19.00 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 30.40 Mn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 65.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 7.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Amphastar Pharmaceuticals | 934.42 Mn | 644.30 Mn | 93.47 Mn | 29.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 29.30 Mn |
| Jun 30, 2026 | 29.30 Mn |
| Mar 31, 2026 | 31.10 Mn |
| Mar 31, 2026 | 31.10 Mn |
| Dec 31, 2025 | 6.21 Mn |
| Dec 31, 2025 | 6.21 Mn |
| Sep 30, 2025 | 23.90 Mn |
| Sep 30, 2025 | 23.90 Mn |
| Jun 30, 2025 | 26.00 Mn |
| Jun 30, 2025 | 26.00 Mn |
| Mar 31, 2025 | 8.39 Mn |
| Mar 31, 2025 | 8.39 Mn |
| Dec 31, 2024 | 5.63 Mn |
| Dec 31, 2024 | 5.63 Mn |
| Sep 30, 2024 | 5.60 Mn |
| Sep 30, 2024 | 5.60 Mn |
| Jun 30, 2024 | 5.78 Mn |
| Jun 30, 2024 | 5.78 Mn |
| Mar 31, 2024 | 7.36 Mn |
| Mar 31, 2024 | 7.36 Mn |